Clariane SE
Clariane SE (CLARI.PA) Stock Overview
Explore Clariane SE’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
1.8B
P/E Ratio
-132.30
EPS (TTM)
$-0.13
ROE
-0.00%
CLARI.PA Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Clariane SE (CLARI.PA) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 60.20, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.76.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -132.30 and a market capitalization of 1.8B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.
Technical Indicators
Company Profile
Clariane SE provides a range of medical and non-medical care and support services for the elderly and people with short or longer-term health issues. The company operates long-term care nursing homes, specialized clinics, and assisted living and shared housing facilities for seniors, as well as offers home care, support, and hospitalization services. It operates approximately health care facilities and networks in France, Germany, Italy, Spain, the Netherlands, Belgium, and the United Kingdom. The company was formerly known as Korian and changed its name to Clariane SE in June 2023. Clariane SE was founded in 2001 and is headquartered in Paris, France.
Sophie Boissard
61,798
21 - 25 rue Balzac, Paris
2023